Estimation of short-term outcomes of ischemic brain stroke in young adult patients across different age subgroups
Introduction. Ischemic stroke (IS) in young patients requires an in-depth study of the age-related characteristics of the clinical course of the disease and its outcomes.D.A. Ryshkov, K.V. Rerikh, L.A. Shchepankevich, M.S. Ponomareva, A.V. Zatynko, E.V. Taneeva, I.N. Novikova
Objective: To assess the early outcomes of IBS in young patients (aged 18–50 years), with a focus on age-related features of the clinical course and the rate of recovery.
Material and methods. A retrospective analysis was performed on clinical data from 75 patients with IS who were admitted to Regional vascular center No. 2 of Novosibirsk State Regional Clinical Hospital between 2023 and 2024. Patients were divided into two age groups: 18–35 years (n = 13) and 36–50 years (n = 62). Demographic characteristics, stroke subtypes (based on the TOAST classification), affected vascular territory, neurological deficit (using NIHSS scale), degree of disability (using the modified Rankin scale, mRS), and mobility (using Rivermead mobility index) at the time of admission and discharge were analyzed.
Results. There were male individuals who predominated among the patients (70.7%). The frequency of ischemic stroke (IS) of undetermined etiology was 69.2% in 18–35 age group and 53.3% in 36–50 age group. Patients aged 18–35 presented with greater stroke severity, as was measured by NIHSS score (7.3 ± 4.3), but showed significantly better recovery by the time of discharge (1.6 ± 1.2) comparatively to the 36–50 age group (6.5 ± 4.6 and 3.2 ± 2.1, respectively; p = 0.041 for the comparison between groups at discharge). On the modified Rankin scale (mRS), patients aged 18–35 exhibited minimal impairments (1.5 ± 1.0), whereas those aged 36–50 showed persistent mild limitations (2.0 ± 1.0; p = 0.040). Estimation using Rivermead index revealed more favorable progress in the 18–35 age group: scores increased from 4.6 ± 3.6 at admission to 13.2 ± 1.6 at discharge, comparatively to 3.3 ± 1.9 and 11.6 ± 2.3, respectively, for the 36–50 age group (p = 0.042 for the comparison between groups at discharge). There were no deaths in the younger group, while the mortality rate in the older group was 3.2%. The differences in outcomes were attributable to the accumulation of modifiable risk factors and the development of cerebral microangiopathy by the age of 35–50, both of which limit neuroplasticity.
Conclusion. Both age groups showed significant recovery rate following ischemic stroke (IS); however, patients aged 18–35 achieved better functional outcomes. This underscores the need for age-based stratification and an individualized approach to the management of young patients with this condition.
Keywords
References
- Bukhari S, Yaghi S, Bashir Z. Stroke in young adults. J Clin Med. 2023;12(15):4999.
PMID: 37568401. PMCID: PMC10420127. https://doi.org/10.3390/jcm12154999
- Yu Q, Tian Y, Jiang N, Zhao F, Wang S, Sun M, et al. Global, regional, and national burden and trends of stroke among youths and young adults aged 15–39 years from 1990 to 2021: Findings from the Global Burden of Disease study 2021. Front Neurol. 2025;16:1535278.
PMID: 40144628. PMCID: PMC11938946. https://doi.org/10.3389/fneur.2025.1535278
- Ariss RW, Minhas AMK, Lang J, Ramanathan PK, Khan SU, Kassi M, et al. Demographic and regional trends in stroke-related mortality in young adults in the United States, 1999 to 2019. J Am Heart Assoc. 2022;11(18):e025903.
PMID: 36073626. PMCID: PMC9683653. https://doi.org/10.1161/JAHA.122.025903
- Imoisili OE, Chung A, Tong X, Hayes DK, Loustalot F. Prevalence of stroke – behavioral risk factor surveillance system, United States, 2011–2022. MMWR Morb Mortal Wkly Rep. 2024;73(20):449–55.
PMID: 38781110. PMCID: PMC11115433. https://doi.org/10.15585/mmwr.mm7320a1
- Lutski M, Zucker I, Shohat T, Tanne D. Characteristics and outcomes of young patients with first-ever ischemic stroke compared to older patients: The National Acute Stroke ISraeli Registry. Front Neurol. 2017:8:421.
PMID: 28871237. PMCID: PMC5566555. https://doi.org/10.3389/fneur.2017.00421
- Kono Y, Terasawa Y, Sakai K, Iguchi Y, Nishiyama Y, Nito C, et al. Risk factors, etiology, and outcome of ischemic stroke in young adults: A Japanese multi-center prospective study. J Neurol Sci. 2020:417:117068.
PMID: 32745720. https://doi.org/10.1016/j.jns.2020.117068
- Wu X, Zou Y, You S, Zhang Y. Distribution of risk factors of ischemic stroke in Chinese young adults and its correlation with prognosis. BMC Neurol. 2022;22(1):26.
PMID: 35030995. PMCID: PMC8759205. https://doi.org/10.1186/s12883-022-02552-1
- Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, et al. Ischaemic stroke in young adults: Predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76(2):191–95.
PMID: 15654030. PMCID: PMC1739502. https://doi.org/10.1136/jnnp.2004.040543
- Farah M, Næss H, Waje-Andreassen U, Nawaz B, Fromm A. Comparison between first-ever ischemic stroke in young adults in 1988–1997 and 2008–2017. Vasc Health Risk Manag. 2023:19:231–35.
PMID: 37082449. PMCID: PMC10112465. https://doi.org/10.2147/VHRM.S398127
- Nacu A, Fromm A, Sand KM, Waje-Andreassen U, Thomassen L, Naess H. Age dependen-cy of ischaemic stroke subtypes and vascular risk factors in western Norway: The Bergen Norwegian Stroke Cooperation Study. Acta Neurol Scand. 2016;133(3):202–7.
PMID: 26032994. PMCID: PMC4744685. https://doi.org/10.1111/ane.12446
- Kono Y, Terasawa Y, Sakai K, Iguchi Y, Nishiyama Y, Nito C, et al. Association between living conditions and the risk factors, etiology, and outcome of ischemic stroke in young adults. Intern Med. 2023;62(19):2813–20.
PMID: 36823091. PMCID: PMC10602838. https://doi.org/10.2169/internalmedicine.0912-22
- Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: Risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol. 2013;70(1):51–57.
PMID: 23108720. https://doi.org/10.1001/jamaneurol.2013.575
- Bejot Y, Daubail B, Jacquin A, Durier J, Osseby GV, Rouaud O, Giroud M. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: The Dijon Stroke Registry. J Neurol Neurosurg Psychiatry. 2014;85(5):509–13.
PMID: 24249786. https://doi.org/10.1136/jnnp-2013-306203
- Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. JACC. 2020;75(23):2921–30.
PMID: 32527401. https://doi.org/10.1016/j.jacc.2020.04.038
- Мхитарян Э.А., Фатеева В.В. Возраст-зависимая церебральная микроангиопатия, ассоциированная с сосудистыми факторами риска: как распознать на гериатрическом приеме. Российский журнал гериатрической медицины. 2024;(1):49–55. [Mkhitaryan EA, Fateeva VV. Age-dependent cerebral microangiopathy associated with vascular risk factors: How to recognize the signs? Rossiyskiy zhurnal geriatricheskoy meditsiny= Russian Journal of Geriatric Medicine. 2024;(1):49–55 (In Russ.)].
EDN: QAARYG. https://doi.org/10.37586/2686-8636-1-2024-49-55
- Ma Z, He W, Zhou Y, Mai L, Xu L, Li C, Li M. Global burden of stroke in adolescents and young adults (aged 15–39 years) from 1990 to 2019: A comprehensive trend analysis based on the global burden of disease study 2019. BMC Public Health. 2024;24(1):2042.
PMID: 39080669. PMCID: PMC11289945. https://doi.org/10.1186/s12889-024-19551-1
- Gao Y, Li D, Lin J, Thomas AM, Miao J, Chen D, et al. Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets. Front Aging Neurosci. 2022:14:961661.
PMID: 36034144. PMCID: PMC9412755. https://doi.org/10.3389/fnagi.2022.961661
- Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267.
PMID: 37433768. PMCID: PMC10336149. https://doi.org/10.1038/s41392-023-01486-5
- Bai T, Yu S, Feng J. Advances in the role of endothelial cells in cerebral small vessel disease. Front Neurol. 2022:13:861714.
PMID: 35481273. PMCID: PMC9035937. https://doi.org/10.3389/fneur.2022.861714
- Широков Е.А., Сапроненкова О.А. Церебральная болезнь мелких сосудов – новые представления о хронической ишемии мозга. Клиническая медицина. 2024;102(3):205–211. [Shirokov EA, Sapronenkova OA. Cerebral small vessel disease – new ideas about chronic cerebral ischemia. Klinicheskaya meditsina = Clinical Medicine (Russian Journal). 2024;102(3):205–211 (In Russ.)].
EDN: SGQMBX. https://doi.org/10.30629/0023-2149-2024-102-3-205-211
- Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, et al. Global burden of small vessel disease-related brain changes on MRI predicts cognitive and functional decline. Stroke. 2020;51(1):170–78.
PMID: 31699021. PMCID: PMC6924941. https://doi.org/10.1161/STROKEAHA.119.026170
- Добрынина Л.А., Гаджиева З.Ш., Кремнева Е.И., Шамтиева К.В., Цыпуштанова М.М., Макарова А.Г. с соавт. Выживаемость, изменения когнитивных функций и состояния головного мозга у пациентов с церебральной микроангиопатией (болезнью мелких сосудов): 5летнее наблюдение. Анналы клинической и экспериментальной неврологии. 2022;16(4):18–28. [Dobrynina LA, Gadzhieva ZSh, Kremneva EI, Shamtieva KV, Tsypushtanova MM, Makarova AG, et al. Survival, cognitive functions, and brain MRI in patients with cSVD: 5-year observation. Annaly klinicheskoy i eksperimental’noy nevrologii = Annals of Clinical and Experimental Neurology. 2022;16(4):18–28 (In Russ.)].
EDN: EZEIVD. https://doi.org/10.54101/ACEN.2022.4.3
- Wei W, Ma D, Li L, Zhang L. Cognitive impairment in cerebral small vessel disease induced by hypertension. Neural Regen Res. 2024;19(7):1454–62.
PMID: 38051887. PMCID: PMC10883517. https://doi.org/10.4103/1673-5374.385841
- van Leijsen EMC, Bergkamp MI, van Uden IWM, Ghafoorian M, van der Holst HM, Norris DG, et al. Progression of white matter hyperintensities preceded by heterogeneous decline of microstructural integrity. Stroke. 2018;49(6):1386–93.
PMID: 29724890/https://doi.org/10.1161/STROKEAHA.118.020980
- Yang Y, Cai X, Zhou M, Chen Y, Pi J, Zhao M, et al. Prevalence and risk factors of cerebral small vessel disease from a population-based cohort in China. Neuroepidemiology. 2023;57(6):413–22.
PMID: 37734325. https://doi.org/10.1159/000533678
- Тынтерова А.М., Баранцевич Е.Р., Шушарина Н.Н., Хоймов М.С., Горбачева А.В. Клинические и иммунные маркеры возраст-зависимой церебральной микроангиопатии. Российский неврологический журнал. 2024;29(5):37–45. [Tynterova AM, Barantsevich ER, Shusharina NN, Khoymov MS, Gorbacheva AV. Clinical and immune markers of age-dependent cerebral microangiopathy. Rossiyskiy nevrologicheskiy zhurnal = Russian Neurological Journal. 2024;29(5):37–45 (In Russ.)].
EDN: DQVWNP. https://doi.org/10.30629/2658-7947-2024-29-5-37-45
- Singh A, Bonnell G, De Prey J, Buchwald N, Eskander K, Kincaid KJ, Wilson CA. Small-vessel disease in the brain. Am Heart J Plus. 2023;27:100277.
PMID: 38511094. PMCID: PMC10945899. https://doi.org/10.1016/j.ahjo.2023.100277
- Wang L, Ge J, Chen Y, Liu Y, Li C, Dong Y, et al. Predictors for the prognosis and recurrence of ischaemic stroke among young Chinese patients: A cohort study. BMJ Open. 2022;12(5):e052289.
PMID: 35501080. PMCID: PMC9062810. https://doi.org/10.1136/bmjopen-2021-052289
- Yahya T, Jilani MH, Khan SU, Mszar R, Hassan SZ, Blaha MJ, et al. Stroke in young adults: Current trends, opportunities for prevention and pathways forward. Am J Prev Cardiol. 2020:3:100085.
PMID: 34327465. PMCID: PMC8315351. https://doi.org/10.1016/j.ajpc.2020.100085
- Reumers SFI, Schellekens MMI, Lugtmeijer S, Maas RPPWM, Verhoeven JI, Boot EM, et al.; ODYSSEY study group. Cognitive impairment in young adults following cerebellar stroke: Prevalence and longitudinal course. Cortex. 2024:178:104–15.
PMID: 38986276. https://doi.org/10.1016/j.cortex.2024.05.021
- Dittrich TD, Schneider T, Katan M, Luft AR, Mono ML, Bolognese M, et al.; Swiss Stroke Registry Investigators. Risk factors, treatments, and outcomes of adults aged <55 years with acute ischemic stroke with undetermined versus determined pathogenesis: A nationwide Swiss cohort study. J Am Heart Assoc. 2024;13(23):e036761.
PMID: 39604021. PMCID: PMC11681592. https://doi.org/10.1161/JAHA.124.036761
- Щепанкевич Л.А., Рерих К.В., Грибачева И.А., Попова Т.Ф., Танеева Е.В., Тяжельников Н.Е. с соавт. Постинсультные когнитивные нарушения у молодых пациентов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2024;124(8):92–96. [Shchepankevich LA, Rerikh KV, Gribacheva IA, Popova TF, Taneeva EV, Tyazhelnikov NE, et al. Post-stroke cognitive impairment in young patients. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(8):92–96 (In Russ.)].
EDN: IGXEQG. https://doi.org/10.17116/jnevro202412408192
- Aderinto N, AbdulBasit MO, Olatunji G, Adejumo T. Exploring the transformative influ-ence of neuroplasticity on stroke rehabilitation: A narrative review of current evidence. Ann Med Surg (Lond). 2023;85(9):4425–32.
PMID: 37663728. PMCID: PMC10473303. https://doi.org/10.1097/MS9.0000000000001137
- Marquez-Ortiz RA, Tesic V, Hernandez DR, Akhter B, Aich N, Boudreaux PM, et al. Neuroimmune support of neuronal regeneration and neuroplasticity following cerebral ischemia in juvenile mice. Brain Sci. 2023;13(9):1337.
PMID: 37759938. PMCID: PMC10526826. https://doi.org/10.3390/brainsci13091337
About the Authors
Danila A. Ryshkov, MD, 1st-year clinical resident in neurology, Novosibirsk State Medical University, Novosibirsk, Russian Federation.E-mail: den-20063@mail.ru
ORCID: https://orcid.org/0009-0004-9474-5309. eLibrary SPIN: 1539-1638
Kseniya V. Rerikh, MD, assistant at the Department of neurology, Novosibirsk State Medical University; neurologist at Regional Vascular Center No. 2, Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation.
E-mail: kseniya.rerikh@yandex.ru
ORCID: https://orcid.org/0000-0002-4141-9161
Larisa A. Shchepankevich, MD, Dr. Sci. (Medicine), associate professor, neurologist, head of the Department of neurology, Novosibirsk State Medical University; head of the Center for Neurology and Neurosurgery, supervisor of the 8th Neurological Department, Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation.
E-mail: shepankevich@rambler.ru
ORCID: https://orcid.org/0000-0001-6951-2205
Maria S. Ponomareva, MD, neurologist at the Center for Neurology and Neurosurgery, Novosibirsk Regional Clinical Hospital; assistant at the Department of neurology, Novosibirsk State Medical University, Novosibirsk, Russian Federation.
E-mail: marisponn@yandex.ru
ORCID: https://orcid.org/0000-0001-5141-3292
Andrey V. Zatynko, MD, head of the Department for patients with acute cerebrovascular disorders, Regional Vascular Center No. 2, Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation.
E-mail: azatynko@mail.ru
ORCID: https://orcid.org/0009-0000-3737-3431
Elena V. Taneeva, MD, head of Regional Vascular Center No. 2, Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation.
ORCID: https://orcid.org/0000-0002-6538-6069
Inna N. Novikova, MD, PhD (Medicine), associate professor of the Department of neurology, Novosibirsk State Medical University, Novosibirsk, Russian Federation.
Email: inna-novikova68@yandex.ru
ORCID: https://orcid.org/0000-0002-8166-8445



